Cary Street Partners Investment Advisory’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $126K | Buy |
282
+9
| +3% | +$4.01K | 0.06% | 301 |
|
|
2025
Q1 | $132K | Buy |
273
+48
| +21% | +$23.3K | 0.08% | 264 |
|
|
2024
Q4 | $90.6K | Sell |
225
-23,995
| -99% | -$9.66M | 0.06% | 266 |
|
|
2024
Q3 | $11.3M | Sell |
24,220
-165
| -0.7% | -$76.7K | 0.42% | 60 |
|
|
2024
Q2 | $11.4M | Buy |
24,385
+745
| +3% | +$349K | 0.46% | 51 |
|
|
2024
Q1 | $9.88M | Buy |
23,640
+378
| +2% | +$158K | 0.42% | 65 |
|
|
2023
Q4 | $9.47M | Buy |
23,262
+518
| +2% | +$211K | 0.45% | 58 |
|
|
2023
Q3 | $7.91M | Buy |
22,744
+549
| +2% | +$191K | 0.43% | 60 |
|
|
2023
Q2 | $7.81M | Buy |
22,195
+6,011
| +37% | +$2.12M | 0.5% | 49 |
|
|
2023
Q1 | $5.1M | Buy |
16,184
+427
| +3% | +$135K | 0.37% | 74 |
|
|
2022
Q4 | $4.55M | Buy |
15,757
+5,489
| +53% | +$1.59M | 0.33% | 79 |
|
|
2022
Q3 | $2.97M | Buy |
+10,268
| New | +$2.97M | 0.24% | 109 |
|
|
2020
Q4 | – | Sell |
-24
| Closed | -$7K | – | 864 |
|
|
2020
Q3 | $7K | Buy |
+24
| New | +$7K | ﹤0.01% | 812 |
|